A2A Adenosine Receptors and Equine Sepsis

Period of Performance: 01/01/2006 - 12/31/2006

$296K

Phase 2 SBIR

Recipient Firm

Adenosine Therapeutics, LLC
310 FOURTH STREET NE, SUITE 201
Charlottesville, VA 22902
Principal Investigator
Firm POC

Abstract

Endotoxemia (Sepsis) affects horses of all breeds and ages and is the leading causes of death in adult horses and foals. Consequently, its economic impact on the equine industry in the United States is devastating. This project seeks to develop new treatments for this disease.